Cannabis

Latest News

November 12th 2026

Digital Gradebook Engagement Scores May Flag Adolescents at Risk for Substance Use

Teacher-recorded classroom engagement scores beat GPA at identifying middle schoolers who reported alcohol or cannabis use by eighth grade.

October 13th 2026

Relief Is Not Free: A Case Study of Athlete Cannabis Use

By Derek H. Suite, MD, MS, Justin E. Morales, MD

September 29th 2026

How Prevalent Is Simultaneous Alcohol-Cannabis Use?

By Psychiatric Times Editors

August 31st 2026

How Do Cannabis Edibles Affect Driving? New Research Insights

By Leah Kuntz

August 20th 2026

NIDA Awards PleoPharma $6.5 Million Grant to Advance Phase 3 Trial of PP-01 for Cannabis Use Disorder

By Leah Kuntz

Latest Videos

Addressing the Treatment Gap in Cannabis Use Disorder

Treating Cannabis Use Disorder & Withdrawal With PP-01: NIDA Grant Accelerates Phase 3 Trial

Developments in Cannabis Withdrawal and Addiction Treatment

Treating Cannabis Addiction and Withdrawal: Latest Clinical Data

Shorts

1:11

Treatment for Cannabis Use Disorder With PP-01

2 months ago

by

Shelli Graham, PhD

CME Content

Video

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

More News

Oral Cannabinoid From MediPharm Shows Significant Reduction in Agitation in Alzheimer Disease and Dementia

ByJessica Walters

July 16th 2026

Oral THC/CBD combo rapidly eases severe dementia agitation in phase 2 trial, with sustained 12-week benefit and similar safety to placebo.

The Psychiatric Impact of Cannabis Policy: More Than a Legal Framework

ByMira Zaboube, BS,Nidal Moukaddam, MD, PhD

July 16th 2026

How shifting cannabis laws shape potency, access, and risk—revealing why anxiety, paranoia, and psychosis can surge when users cross regulatory borders.

Treating Patients With First-Episode Psychosis: Lessons From McLean OnTrack

ByMichael Murphy, MD, PhD,Allison Nelson-Eliot, LICSW

June 18th 2026

Key steps for first-episode psychosis: team-based care, low-dose meds, relapse planning, family support, and cannabis harm reduction.

Cannabis and Psychosis Risk: How Legalization Could Impact Clinical Practice

ByFawad Taj, MD

May 5th 2026

New cohort and global data link teen high-potency cannabis use to higher psychosis, bipolar, and suicide risks. Here's what psychiatrists and mental health clinicians should know in the era of legalization.